The Additional Hetero Ring Is Five-membered Patents (Class 546/283.4)
  • Patent number: 6605625
    Abstract: Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations including their use as antiarrhythmic active compounds, for example, for the treatment and prophylaxis of atrial arrhythmias, e.g. atrial fibrillation (AF) or atrial flutters. Compounds of the invention include compounds of the formula I in which: A1, A2, A3, A4, A5, A6, A7 and A8 independently of one another are chosen from nitrogen, CH and CR(5), at least four of these groups being CH, and wherein all other variables are as defined here.
    Type: Grant
    Filed: November 29, 2001
    Date of Patent: August 12, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Stefan Peukert, Joachim Brendel, Horst Hemmerle, Heinz-Werner Kleemann
  • Publication number: 20030149078
    Abstract: Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more fluoro-substituted benzenesulfonyl compounds corresponding to Formula I: 1
    Type: Application
    Filed: December 13, 2002
    Publication date: August 7, 2003
    Applicant: Pharmacia Corporation
    Inventors: David L. Brown, Matthew J. Graneto, Cindy L. Ludwig, John M. Molyneaux, John J. Talley
  • Publication number: 20030149040
    Abstract: This invention is directed to poly-hydroxylated monocyclic N-heterocyclic derivatives selected from the following formulae: 1 2
    Type: Application
    Filed: January 24, 2003
    Publication date: August 7, 2003
    Applicant: Berlex Laboratories, Inc.
    Inventor: Gary B. Phillips
  • Patent number: 6596863
    Abstract: Process for producing a nitroetheneamine derivative or its stereoisomer, its tautomer or a salt thereof comprising reacting a compound of the formula with a compound of the formula R6—CH2NO2 to obtain a compound of the formula and reacting the resulting compound with a compound of the formula
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: July 22, 2003
    Assignee: Ishihara Sangyo Kaisha, Ltd.
    Inventors: Fuminori Kato, Keizo Miyata, Hirohiko Kimura, Kazuhiro Yamamoto, Hiroyuki Ikegami, Hiromi Takeo
  • Publication number: 20030135046
    Abstract: Disclosed are novel 2-(5-halopyridyl) and 2-(5-halopyrimidinyl) magnesium halides, processes of making and their use in the efficient synthesis in their respective 5-halo-2-substituted pyridines and pyrimidines.
    Type: Application
    Filed: December 6, 2002
    Publication date: July 17, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Jinhua J. Song, Nathan K. Yee
  • Publication number: 20030114670
    Abstract: A process for preparing a compound of the formula 1
    Type: Application
    Filed: December 12, 2002
    Publication date: June 19, 2003
    Inventors: Robert L. Dow, Steven R. Schneider
  • Publication number: 20030109532
    Abstract: New 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds of Formula (1) wherein X is N, CH, or C, however X may only be C when the compound comprises a double bond at the dotted line; R1 is OSO2CF3, OSO2CH3, SOR5, SO2R5, COR5, CN, NO2, CONHR5, CF3, 3-thiophene, 2-thiophene, 3-furane, 2-furane, F, Cl, Br, or I; R2 is a C1-C4 alkyl, an allyl, CH2SCH3, CH2CH2OCH3, CH2CH2CH2F, CH2CF3, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, or —(CH2)—R6; R3 and R4 are independently selected from the group consisting of H and C1-C4 alkyls, however both R3 and R4 cannot be H at the same time; R5 is C1-C3 alkyls, CF3, or N(R2)2; R6 is a C3-C6 cycloalkyl, 2-tetrahydrofurane, or 3-tetra-hydrofurane, as well as pharmaceutically acceptable salts thereof are disclosed. Also pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used are disclosed.
    Type: Application
    Filed: November 20, 2002
    Publication date: June 12, 2003
    Inventors: Clas Sonesson, Bengt Andersson, Susanna Waters, Nicholas Waters, Ingela Marianne Svan, Liselott Lilja Ronnqvist
  • Publication number: 20030109687
    Abstract: Compounds of the formula
    Type: Application
    Filed: August 5, 2002
    Publication date: June 12, 2003
    Inventors: Tae K. Song, Min Teng, Roshantha A. Chandraratna
  • Publication number: 20030100759
    Abstract: The present invention relates to dideoxynucleoside analog compounds containing a dideoxy ribofuranosyl moiety that exhibit selective anti-viral activity coupled with substantially low toxicity toward the host cells. In particular, the compounds according to the present invention show potent inhibition of the replication of the human immunodeficiency virus (HIV), while remaining substantially inert toward host cell DNA. Compounds according to the present invention exhibit primary utility as agents for inhibiting the growth or replication of retroviruses, particularly HIV. The compounds of the invention comprise a (2,3 ′-dideoxy-&bgr;-ribofuranosyl) ring coupled to a heterocyclic nucleobase that lacks an “O2 carbonyl”, that enables them to selectively react with and inhibit viral reverse transcriptase, while remaining substantially unreactive toward human DNA polymerases.
    Type: Application
    Filed: March 13, 2002
    Publication date: May 29, 2003
    Inventors: Larry W. McLaughlin, Andrew W. Fraley, DongLi Chen, Tao Lan
  • Publication number: 20030083362
    Abstract: The present invention relates to novel 2,5-bis {[alkyl (or aryl) imino] aminophenyl} furans and thiophenes of the general formula 1
    Type: Application
    Filed: November 6, 2001
    Publication date: May 1, 2003
    Inventors: David W. Boykin, Richard R. Tidwell, W. David Wilson, John R. Perfect, Chad F. Stephens
  • Publication number: 20030073709
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: August 8, 2002
    Publication date: April 17, 2003
    Applicant: Wyeth
    Inventors: Paul J. Dollings, Robert E. McDevitt, Folake O. Adebayo
  • Patent number: 6514996
    Abstract: An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R1 and R2 independently represent hydrogen, lower alkyl, cyano, —(CH2)n—E1—CO—G1 (wherein E1 represents a bond, O, or NH; and G1 represents hydrogen, substituted or unsubstituted lower alkyl, OR6, or NR7R8; and n represents an integer of 0 to 4), or the like; R1 and R2 are combined to represent a saturated carbon ring together with a carbon atom adjacent thereto; or R2, and R11 or R13 described below are combined to form a single bond; R3 represents hydrogen, phenyl, or halogen; R4 represents hydroxy, lower alkoxy, or the like; A represents —C(R9)(R10)— or O; B represents O, NR11, —C(R12)(R13)—, or —C(R14)(R15)—C(R16)(R17)—; D represents (i) —C(R18)(R19)—X— (wherein X represents —C(R21)(R22)—, S, or NR23), (ii) —C(R19a)═Y— [Y represents —C(R24)—Z— (wherein Z represents C
    Type: Grant
    Filed: November 19, 1997
    Date of Patent: February 4, 2003
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Etsuo Ohshima, Takashi Kawakita, Koji Yanagawa, Kyoichiro Iida, Rie Koike, Yoshisuke Nakasato, Tohru Matsuzaki, Kenji Ohmori, Soichiro Sato, Hidee Ishii, Haruhiko Manabe, Michio Ichimura, Fumio Suzuki
  • Publication number: 20030018186
    Abstract: Novel monocyclic L-Nucleoside compounds have the general formula 1
    Type: Application
    Filed: April 9, 2002
    Publication date: January 23, 2003
    Inventors: Kanda Ramasamy, Robert Tam, Devron Averett
  • Publication number: 20030018057
    Abstract: Novel thiol derivatives of formula I 1
    Type: Application
    Filed: June 13, 2002
    Publication date: January 23, 2003
    Inventors: Cynthia Anne Fink, Faribroz Firooznia
  • Publication number: 20030013744
    Abstract: A class of 3,4-diaryl substituted thiophene, furan and pyrrole derivatives and analogs thereof, pharmaceutical compositions containing them and methods of using them to treat inflammation and inflammation-related disorders.
    Type: Application
    Filed: July 1, 2002
    Publication date: January 16, 2003
    Applicant: G.D. Searle & Co.
    Inventors: John J. Talley, Stephen R. Bertenshaw, Paul W. Collins, Thomas D. Penning, David B. Reitz, Roland S. Rogers
  • Publication number: 20030004169
    Abstract: New substituted 4-phenyl N-alkyl)-piperazine and 4-phenyl-N-alkyl)-piperidine compounds of Formula (1) wherein X is N, CH, or C, however X may only be C when the compound comprises a double bind at the dotted line; R1 is CF3, OSO2CF3, OSO2CH3, SOR7, SO2R7, COR7, CN, OR3, NO2, CONHR3, 3-thiophene, 2-thiophene, 3-furane, 2-furane, F, Cl, Br, or I; R2 is F, Cl, Br, I, CN, CF3, CH3, OCH3, OH, and NH2; R3 and R4 are independently H or a C1-C4 alkyl; R5 is a C1-C4 alkyl, an allyl, CH2SCH3, CH2CH2OCH3, CH2CH2CH2F, CH2CF3, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, or —(CH2)—R6; R6 is a C3-C6 cycloalkyl, 2-tetrahydrofurane, or 3-tetrahydrofurane; R7 is a C1-C3 alkyl, CF3, or N(R4)2, and pharmaceutically acceptable salts thereof are disclosed. Also pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used for treatment of disorders in the central nervous system are disclosed.
    Type: Application
    Filed: June 18, 2002
    Publication date: January 2, 2003
    Inventors: Clas Sonesson, Bengt Andersson, Susanna Waters, Nicholas Waters, Joakim Tedroff
  • Patent number: 6498172
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: December 24, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • Publication number: 20020193605
    Abstract: Dihydropyridine derivatives represented by the following formula: 1
    Type: Application
    Filed: December 21, 2001
    Publication date: December 19, 2002
    Applicant: AJINOMOTO CO. INC
    Inventors: Akira Nakajo, Munetaka Tokumasu, Morikazu Kito, Akira Takahara, Yukitsugu Ono, Tomoko Takeda, Yuki Kajigaya, Hajime Koganei
  • Patent number: 6495571
    Abstract: New pyridine compounds are provided along with their method of preparation. The compounds are useful as intermediates in preparing new anticancer agents. A few of the pyridine compounds are also useful for treating cancer.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: December 17, 2002
    Assignee: Southern Research Institute
    Inventors: Robert F. Struck, Herbert M. Blatter, Anita Tiwari
  • Patent number: 6495576
    Abstract: Compounds of formula (I) may be useful in treating diseases prevented by or ameliorated with potassium channel openers.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: December 17, 2002
    Assignee: Abbott Laboratories
    Inventors: Michael E. Kort, Robert J. Gregg, William A. Carroll, Arturo Perez Medrano, Jürgen Dinges, Fatima Z. Basha
  • Patent number: 6495550
    Abstract: The present invention provides a genus of pyridine-substituted benzanilides that are useful as openers of potassium ion channels. The compounds of the invention are of use in both therapeutic and diagnostic methods.
    Type: Grant
    Filed: February 2, 2001
    Date of Patent: December 17, 2002
    Assignee: ICAgen, Inc.
    Inventors: Grant McNaughton-Smith, Paul Christopher Fritch, George Salvatore Amato
  • Patent number: 6492374
    Abstract: The present invention relates to benzofuran derivatives having general Formula (I) wherein A is selected from (1), (2), (3), (4) wherein Z is O or S; s is 0 or 1; q is 0 or 1; R4 is hydrogen, C1-6-alkyl, C2-6-alkenyl, C26-alkynyl, C1-6-alkyl-aryl, or C1-6-alkyl-O-aryl; D is a spacer group selected from branched or straight chain C1-6-alkylene, C2-6-alkenylene and C2-6-alkynylene; its enantiomers, and pharmaceutically acceptable acid addition salt thereof. The compounds are potently binding to the 5-HT1A receptor.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: December 10, 2002
    Assignee: H. Lundbeck A/S
    Inventors: Kim Andersen, Mario Rottländer, Klaus Peter Bøgesø, Henrik Pedersen, Thomas Ruhland, Robert Dancer
  • Patent number: 6489344
    Abstract: New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: December 3, 2002
    Assignee: Chiron Corporation
    Inventors: John M. Nuss, Stephen D. Harrison, David B. Ring, Rustum S. Boyce, Sean P. Brown, Dane A. Goff, Kirk W. Johnson, Keith B. Pfister, Savithri Ramurthy, Paul A. Renhowe, Lynn Seely, Sharadha Subramanian, Allan S. Wagman, Xiaohui A. Zhou
  • Publication number: 20020177723
    Abstract: 2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e., by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase.
    Type: Application
    Filed: April 11, 2000
    Publication date: November 28, 2002
    Inventors: Xiong Cai, Sajjat Hussoin, San-Bao Hwang, David Killian, T.Y. Shen
  • Publication number: 20020165201
    Abstract: The invention relates to compounds of the formula I 1
    Type: Application
    Filed: November 20, 2001
    Publication date: November 7, 2002
    Inventors: Ernst Binderup, Pernille-Julia Vig Hjarnaa
  • Patent number: 6465493
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1, R2 and R3 are various substituent groups; and one of X1 and X2 is N or CR′, and the other is NR′ or CHR′ wherein R′ is hydrogen, OH, C1-6alkyl, or C3-7cycloalkyl; or when one of X1 and X2 is N or CR′ then the other may be S or O; and their use as pharmaceuticals.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: October 15, 2002
    Assignee: Smithkline Beecham Corporation
    Inventors: Joelle L. Burgess, James F. Callahan
  • Publication number: 20020147222
    Abstract: Compounds having a selective N-type calcium channel antagonistic activity are provided.
    Type: Application
    Filed: December 20, 2001
    Publication date: October 10, 2002
    Applicant: AJINOMOTO CO. INC
    Inventors: Chika Nakanishi, Yoko Masuzawa, Masako Hagihara, Takashi Yamamoto, Hiroyuki Matsueda, Seiji Ohno, Seiji Niwa, Morikazu Kito, Akira Takahara, Yukitsugu Ono, Tomoko Takeda, Yuki Kajigaya, Hajime Koganei
  • Patent number: 6458950
    Abstract: A compound shown by the formula II, wherein Het is a mono- or polycyclic heterocyclic group comprising one or more hetero atoms selected from the group consisting of N, O and S which may be the same or different from each other; R1 is hydrogen, an optionally substituted lower alkyl or an optionally substituted lower alkenyl; A is an optionally substituted lower alkylene, an optionally substituted lower alkenylene or a single bond; B is an optionally substituted imino or a single bond; or A and B taken together may form a single bond; and D is a single bond or a group of the formula (a):
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: October 1, 2002
    Assignee: Shionogi & Co., Ltd.
    Inventors: Yasuhiro Nishitani, Koji Ishikura
  • Patent number: 6458789
    Abstract: The present invention relates to novel 2-aminopyridine derivative compounds of the following formula: wherein R1 to R5 have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing 2-aminopyridine derivative compounds.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: October 1, 2002
    Assignee: Lion Bioscience AG
    Inventors: Behrouz Forood, Brenton T. Flatt, Christophe Chassaing, Alan K. Katritzky
  • Patent number: 6451845
    Abstract: This invention provides compounds of Formula I having the structure wherein R1 and R2 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, halogen, perfluoroalkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, thienyl, furyl, phenyl or phenyl substituted with trifluoromethyl, chloro, methoxy, or trifluoromethoxy; R3 and R4 are each, independently, hydrogen, carboxyl, hydroxyl, hydoxyalkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, perfluoroalkoxy of 1-6 carbon atoms, alkanoyloxy of 2-7 carbon atoms, perfluoroalkanoyloxy of 2-7 carbon atoms, arylalkoxy of 7-15 carbon atoms, aryloxy of 6-12 carbon atoms, aroyloxy of 6-12 carbon atoms, aryloxycarbonyl of 7-13 carbon atoms, alkoxycarbonyl of 2-7 carbon atoms, perfluoroalkoxycarbonyl of 2-7 carbon atoms, alkyl of 1-6 carbon atoms, perfluoroalkyl of 1-6 carbon atoms, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl group, tetrazolyl, mercapto, nitrile, nitro, amino, —NHSO2CF3, carbamoyl, carbo
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: September 17, 2002
    Assignee: Wyeth
    Inventors: Paul J. Dollings, Robert E. McDevitt, Folake O. Adebayo
  • Patent number: 6451792
    Abstract: A medical composition containing, as an active constituent, a nitroetheneamine derivative represented by the formula (I): wherein the substituents are as defined in the disclosure, its stereoisomers, its tautomers or a salt thereof.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: September 17, 2002
    Assignee: Ishihara Sangyo Kaisha Ltd.
    Inventors: Fuminori Kato, Keizo Miyata, Hirohiko Kimura, Kazuhiro Yamamoto, Hiroyuki Ikegami, Hiromi Takeo
  • Patent number: 6437129
    Abstract: Compounds of the formula wherein X, L, Y, A, B, W, R1, m, p and r are defined above.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: August 20, 2002
    Assignee: Allergan Sales, LLC
    Inventors: Min Teng, Tien T. Duong, Roshantha A. Chandraratna
  • Publication number: 20020111494
    Abstract: Dihydropyridine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel. They are used as remedies for various diseases relating to the N-type calcium channel such as encephalopathies caused by the ischemia in the acute phase after the onset of cerebral infarction, cerebral hemorrhage or the like, Alzheimer's disease, etc.
    Type: Application
    Filed: December 13, 2001
    Publication date: August 15, 2002
    Applicant: AJINOMOTO CO., INC.
    Inventors: Hisayuki Uneyama, Seiji Niwa, Tomoyuki Onishi
  • Publication number: 20020107400
    Abstract: The present invention relates to hitherto unknown compounds of formula (I) or their tautomeric forms, 1
    Type: Application
    Filed: February 4, 2002
    Publication date: August 8, 2002
    Applicant: Leo Pharmaceutical Products Ltd. A/S
    Inventors: Charlotte Schou Hunneche, Erik Rytter Ottosen
  • Publication number: 20020095033
    Abstract: Novel monocyclic L-Nucleoside compounds have the general formula 1
    Type: Application
    Filed: December 31, 2001
    Publication date: July 18, 2002
    Applicant: ICN Pharmaceuticals, Inc.
    Inventors: Kandasamy Ramasamy, Robert Tam, Devron Averett
  • Publication number: 20020091262
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: October 16, 2001
    Publication date: July 11, 2002
    Applicant: Allergan
    Inventors: Min Teng, Tien T. Duong, Roshantha A. Chandraratna
  • Patent number: 6413979
    Abstract: The present invention relates to a cyclopentenopyridine derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, wherein Ar is a phenyl group or the like. R1 is a mono- or di-C1-C6 alkylamino group or the like, and R2 is a hydroxyl group or the like, a process for its production and its use.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: July 2, 2002
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Takashi Hayama, Norikazu Otake, Masaru Nishikibe
  • Patent number: 6391893
    Abstract: New pyridine compounds are provided along with their method of preparation. The compounds are useful as intermediates in preparing new anticancer agents. A few of the pyridine compounds are also useful for treating cancer.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: May 21, 2002
    Assignee: Southern Research Institute
    Inventors: Robert F. Struck, Herbert M. Blatter, Anita Tiwari
  • Patent number: 6392047
    Abstract: Biaryls, e,g,. biphenyls, phenylpyridines, phenylfurans, phenylpyrroles, phenylthiophenes, bipyridines, pyridylfurans or pyridylpyrroles are prepared in high yields by coupling aromatics with an aromatic boric acid or boric ester in the presence of a palladaphosphacyclobutane catalyst.
    Type: Grant
    Filed: July 13, 2000
    Date of Patent: May 21, 2002
    Assignee: Clariant GmbH
    Inventors: Holger Geissler, Steffen Haber, Andreas Meudt, Frank Vollmueller, Stefan Scherer
  • Patent number: 6384060
    Abstract: The present invention relates to novel substituted pyridine compounds of Formula (I) wherein the moiety Z, R1, R2 and R3 are as herein defined, having estrogenic activity, to processes for their preparation, to a combinatorial library and solid phase methods for preparing libraries of the compounds, to utilizing libraries of the compounds for drug discovery, to methods of treatment and to pharmaceutical compositions thereof.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: May 7, 2002
    Assignee: American Home Products Corporation
    Inventors: Chingfan Chiu, Zhilian Tang, John W. Ellingboe
  • Patent number: 6384058
    Abstract: The present invention relates to novel substituted pyridine compounds of Formula (I) wherein the moiety Z, R1, R2 and R3 are as herein defined, having estrogenic activity, to processes for their preparation, to a combinatorial library and solid phase methods for preparing libraries of the compounds, to utilizing libraries of the compounds for drug discovery, to methods of treatment and to pharmaceutical compositions thereof.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: May 7, 2002
    Assignee: American Home Products Corporation
    Inventors: Chingfan Chiu, Zhilian Tang, John W. Ellingboe
  • Patent number: 6376502
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: April 23, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • Patent number: 6376518
    Abstract: Acyl derivatives of 4-demethylpenclomedine are provided along with pharmaceutical compositions containing them and use for treating cancer. A method for preparing the derivatives is also provided.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: April 23, 2002
    Assignee: Southern Research Institute
    Inventor: Robert F. Struck
  • Patent number: 6369083
    Abstract: The present invention provides novel 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamide compounds with polyether substituents on the pyridine ring, their use as fungicidal compounds, and their use in fungicidal compositions comprising at least one of the 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamide compounds as the active ingredient.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: April 9, 2002
    Assignee: Dow AgroSciences LLC
    Inventors: Emily J. Canada, Carl P. Denny, Christopher S. Galka, Neil V. Kirby, Marc McKennon, Mary E. Pieczko, Rebecca L. Rezac, Brent J. Rieder, John K. Swayze, Chrislyn M. Carson, David D. Johnson, Gregory M. Kemmitt
  • Publication number: 20020035257
    Abstract: The present invention provides novel 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamide compounds with (derivatised) hydroxyalkyl substituents on the pyridine ring, their use as fungicidal compounds, and their use in fungicidal compositions comprising at least one of the 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamide compounds as the active ingredient.
    Type: Application
    Filed: August 30, 2001
    Publication date: March 21, 2002
    Inventors: Emily J. Canada, Robert P. Gajewski, Christopher S. Galka, Neil V. Kirby, Irene M. Morrison, Jeannie R. Philips, Mary E. Pieczko, Brent J. Rieder, Chrislyn M. Carson, Zhengyu Huang
  • Publication number: 20020035259
    Abstract: The present invention provides novel 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamide compounds with (derivatised) hydroxyalkyl substituents on the pyridine ring, their use as fungicidal compounds, and their use in fungicidal compositions comprising at least one of the 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamide compounds as the active ingredient.
    Type: Application
    Filed: August 30, 2001
    Publication date: March 21, 2002
    Inventors: Emily J. Canada, Christopher S. Galka, Robert P. Gajewski, Neil V. Kirby, Irene M. Morrison, Mary E. Pieczko, Chrislyn M. Carson, Jeannie R. Phillips, Brent J. Rieder, Zhengyu Huang
  • Publication number: 20020032174
    Abstract: The invention relates to polycyclic aryl and heteroaryl substituted 4 pyridone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
    Type: Application
    Filed: April 4, 2001
    Publication date: March 14, 2002
    Inventors: Michael S. South, Chun C. Ma, Kevin J. Koeller, Hayat K. Rahman, William L. Neumann
  • Patent number: 6355653
    Abstract: The invention relates to compounds of formula wherein R1 is a 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, —(CH2)nOH, halogen or lower alkoxy, and wherein the heteroaryl groups may be optionally linked to the pyrazole ring via an alkylene or alkenyl group, or is phenyl, optionally substituted by one or two substituents being lower alkyl, hydroxy-lower alkyl, halogen, hydroxy or lower alkoxy or is —O(CH2)n,phenyl, benzofuryl, indolyl or benzothiophenyl, or is —S-lower alkyl; R2 and R4 are independently from each other hydrogen, cyano or —S(O)2-phenyl; R3 is hydrogen, halogen or is a 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, —(CH2)n-aryl, hydroxy, halogen, lower alkoxy, morpholin
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: March 12, 2002
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Gerda Huber Trottmann, Walter Hunkeler, Roland Jakob-Roetne, Gavin John Kilpatrick, Matthias Heinrich Nettekoven, Claus Riemer
  • Publication number: 20020026050
    Abstract: Heterocyclic-substituted compounds of the formula 1
    Type: Application
    Filed: June 13, 2001
    Publication date: February 28, 2002
    Inventors: Samuel Chackalamannil, Mariappan V. Chelliah, Yan Xia
  • Patent number: 6350762
    Abstract: Dihydropyridine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel. They are used as remedies for various diseases relating to the N-type calcium channel.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: February 26, 2002
    Assignee: Ajinomoto Co., Inc.
    Inventors: Seiji Niwa, Seiji Ohno, Tomoyuki Onishi, Morikazu Kito, Akira Takahara, Yukitsugu Ono, Hisayuki Uneyama